Teos will look to distribute its cash reserves to shareholders, along with proceeds raised from selling pipeline assets.

Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...

GSK and Spero Therapeutics’ Phase III trial of their oral antibiotic for complicated urinary tract infections (cUTI) will end ...

In a second piece of good news in the development of new antimicrobials this week, GSK has said it will file its oral ...

Leena Tewari, USV Pharmaceuticals chairperson, purchases luxury Mumbai apartments for Rs 639 crore. This deal sets a new real ...

The Nifty 50 slipped 63 points, or 0.3%, to close at 24,752, while the Sensex shed 240 points, or 0.29%, ending at 81,312.

Major health sector news includes GSK and Spero stopping a UTI drug trial due to early success, Brazil's bird flu cases and ...

US biotech iTeos Therapeutics (Nasdaq: ITOS) is preparing to wind down its operations and halt clinical work, as it looks to ...

Spero Therapeutics, Inc. (NASDAQ: SPRO) saw its stock surge by 240% on May 28 following the company’s announcement of the ...

Friday, saw another successful edition of the Gabii sa Kabilin a one-night event that featured cultural shows and exhibits ...

The natural history of chronic hepatitis B virus (HBV) infection is driven by complex interactions among virological, host, ...